SNGX News and Press, Soligenix Inc. From 01/02/24

2024-01-02 10:09:39 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Soligenix Inc (NASDAQ: ...

Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses PR Newswire Single-vial thermostabilized bivalent vaccine demonstrates simultaneous protection against two lethal virus...

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery PR Newswire HyBryte™ has potential to address a critical gap in treatment of early-stage CTCL PRINCETON, N.J. , Dec. 1, 2023 /PRNewswire/ --...

2023-11-30 14:00:55 ET More on Soligenix Seeking Alpha’s Quant Rating on Soligenix Historical earnings data for Soligenix Financial information for Soligenix For further details see: Soligenix wins FDA nod to conduct trial for rare disease therapy

Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's Disease PR Newswire Pipeline Expansion of Novel Innate Defense Regulator Technology PRINCETON, N.J. , Nov. 30, 2023 /PRN...

2023-11-13 07:50:45 ET More on Soligenix Seeking Alpha’s Quant Rating on Soligenix Historical earnings data for Soligenix Financial information for Soligenix For further details see: Soligenix GAAP EPS of -$0.16 beats by $0.13, revenue of $0.1M mis...

Soligenix Announces Recent Accomplishments And Third Quarter 2023 Financial Results PR Newswire PRINCETON, N.J. , Nov. 13, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on devel...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Soligenix Inc. (SNGX) is expected to report $-0.44 for Q3 2023

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting PR Newswire PRINCETON, N.J. , Oct. 20, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focuse...